Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Deficiency and Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Serum 25-hydroxyvitamin D level \<20 ng/ml (\<50 nmol/L)~* Diagnosed with atopic dermatitis by a CHW pediatric dermatologist~* Age 1-18 years old~* Primary residence in Milwaukee County~* Moderate and severe atopic dermatitis (Severity Scoring of Atopic Dermatitis \[SCORAD\] score greater than 15)~* On clinic protocol treatment for their atopic dermatitis (desonide ointment twice daily for the face and groin, triamcinolone 0.1% ointment twice daily for other areas)

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Standard dose vitamin D (Type: ACTIVE_COMPARATOR): Treatment with cholecalciferol 400 IU daily at home.
- High dose vitamin D (Type: ACTIVE_COMPARATOR): Treatment with ergocalciferol 300,000 IU (6 capsules of 50,000 IU) as a single oral dose observed in clinic.

Based on this trial design, predict the completion outcome and termination type (if applicable).